NCT04760561 is a NA clinical trial of prone position group in Prone Position, sponsored by Damanhour University.

Who is sponsoring NCT04760561?

NCT04760561 is sponsored by Damanhour University.

What drugs are being tested in NCT04760561?

Interventions in NCT04760561: prone position group.

What condition does NCT04760561 study?

NCT04760561 studies Prone Position, Coronavirus Disease 2019, Oxygenation.

Is NCT04760561 still recruiting?

NCT04760561 is currently completed. Last updated 4 February 2022.

Last reviewed 2022-02-04 · How we verify

NCT04760561

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Awake Prone Positioning for Non-intubated COVID-19 Patients

Completed NA Last updated 4 February 2022

What this trial tests

NA trial testing prone position group in Prone Position in 82 participants. Completed in 20 April 2021.

Timeline

20 February 2021

Primary endpoint
20 March 2021

20 April 2021

Quick facts

Lead sponsor	Damanhour University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	82
Start date	20 February 2021
Primary completion	20 March 2021
Estimated completion	20 April 2021
Sites	1 location across Egypt

Drugs / interventions tested

prone position group

Conditions studied

Prone Position — all drugs for Prone Position →
Coronavirus Disease 2019 — all drugs for Coronavirus Disease 2019 →
Oxygenation — all drugs for Oxygenation →

Sponsor

Damanhour University

Who can join

Adults 18 to 75, any sex, with Prone Position or Coronavirus Disease 2019. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The burden of coronavirus disease 2019 (COVID-19) pandemic is still on a rising course making a great stress on medical resources throughout the world. Although most of COVID-19 patients require non-invasive oxygenation and ventilation, rapid progression to hypoxemic respiratory failure and then acute respiratory distress syndrome (ARDS) can occur in some COVID19 patients due to prolonged or unaddressed hypoxia. Prone positioning is a common supportive ventilation strategy to improve oxygenation in critically ill patients with ARDS. Recent studies point out the potential benefits of using this strategy for non-intubated awake COVID 19 patients who are hypoxic. Despite several retrospective cohort studies have been conducted to identify impact of the prone positioning in awake non-intubated COVID-19 patients, experimental studies are very rare. This study therefore aims to evaluate the effects of self-prone positioning on oxygenation and physiological outcomes among awake-non intubated patients with COVID-19.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of awake-prone positioning on oxygenation and physiological outcomes in non-intubated patients with COVID-19: A randomized controlled trial.
Othman SY, El-Menshawy AM, Mohamed AM. · · 2023 · cited 5× · PMID 35909384 · DOI 10.1111/nicc.12833

Verify or expand the search:

Other recruiting trials for Prone Position

Currently open trials in the same condition.

NCT07176624 — The PRE-VAIL Study · NA · recruiting
NCT07138872 — Hemodynamic Effects of Surgical Position in Prone vs. Supine Percutaneous Nephrolithotomy · NA · recruiting
NCT06827184 — By Assessing the Continuous Respiratory Physiological Changes Through Prone Position, Determine the Optimal Duration for · recruiting
NCT06215209 — Effect of PP in Patients With Ultra-low VT · recruiting
NCT05878275 — Supporting Infant Development Through Tummy Time, Positioning, and Limiting Baby Gear · NA · recruiting

Other Damanhour University trials

Trials by the same sponsor.

NCT07307911 — Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy · Phase 2 · completed
NCT07341893 — Sacubitril-valsartan in Patients With Heart Failure. · NA · recruiting
NCT07063628 — Triglyceride-Glucose Indices and Left Ventricular Speckle Tracking in Predicting Coronary Artery Disease Severity · completed
NCT06849388 — Effect of HeartMath Intervention on Stress, Emotional Vitality and Sense of Coherence · NA · recruiting
NCT07179302 — Pre- and Post-TAVI Patient Assessment: Advancing Outcome Precision in Aortic Valve Therapy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04760561 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Damanhour University
Last refreshed: 4 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04760561.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing